Specimen SS-F-AST-302 // ASTRINGENCY · IFI-A
Ellagitannin Engineering III-PR-B
Punica granatum
Pomegranate
Target Trait
3.28×
fold-change
Ellagic acid/ellagitannin scaffold accumulation
Technical Specifications
SKU
SS-F-AST-302
Genomic Edits
8
GC Content
47.6%
Construct Length
4,267 bp
Promoter System
Ubiquitin / T7
Expression System
Protoplast PEG-fusion
Host Strain
PEG-mediated
Receptor Target
Polyphenol-astringency axis
IFI Score
328
Pathway Edits
- UGGT overexpression (galloyl-UDP-glucosyltransferase) for galloyl-glucose scaffold initiation
- laccase-ELG upregulation for oxidative C-C galloyl coupling toward ellagic acid
- PGT polygalloylglucoside transferase amplification for ellagitannin polymerization
- cytochrome-b5 electron carrier co-expression for laccase-ELG redox support
- UGGT/laccase-ELG bicistron optimization for coupled galloylation-oxidation
- Protoplast PEG-fusion transient and stable integration protocol
- Enhanced flux via 5'UTR synthetic leader sequence optimization
Key Interventions
IFI Subscale Profile
IFI Profile
Use Case
Commercial ellagitannin ingredient production, mid-range pomegranate nutraceutical R&D, beverage antioxidant formulation. Enhanced variant for premium or research-grade applications requiring peak astringency fidelity.
License
$1549 · Tier III License
Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.
Already purchased?